Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 29-Feb-24 8:23 PM View:  | Eagle Pharmaceuticals, Inc. (EGRX) | 27-Feb-24 | Grant | 3,800 | -- | -- | 8% 45.75K to 49.55K | |
| 29-Feb-24 8:23 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 27-Feb-24 | Payment of Exercise | 1,589 | $6.44 | $10,233.20 | (3%) 49.55K to 47.96K | |
| 06-Feb-24 5:09 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 02-Feb-24 | Payment of Exercise | 934 | $5.85 | $5,463.90 | (2%) 46.68K to 45.75K | |
| 09-Jan-24 5:01 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 05-Jan-24 | Payment of Exercise | 735 | $5.13 | $3,770.55 | (2%) 47.42K to 46.68K | |
| 20-Dec-23 4:34 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 18-Dec-23 | Payment of Exercise | 452 | $4.76 | $2,151.52 | (< 1%) 47.87K to 47.42K | |
| 02-Mar-23 4:20 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 01-Mar-23 | Grant | 18,500 | -- | -- | 63% 29.37K to 47.87K | |
| 02-Mar-23 4:20 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 28-Feb-23 | Payment of Exercise | 718 | $28.00 | $20,104.00 | (2%) 30.09K to 29.37K | |
| 06-Feb-23 4:48 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 02-Feb-23 | Payment of Exercise | 785 | $34.09 | $26,760.70 | (3%) 30.87K to 30.09K | |
| 31-Jan-23 6:21 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 30-Jan-23 | Payment of Exercise | 601 | $33.21 | $19,959.20 | (2%) 31.47K to 30.87K | |
| 09-Jan-23 4:34 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 05-Jan-23 | Payment of Exercise | 734 | $29.26 | $21,476.80 | (2%) 32.21K to 31.47K | |
| 21-Dec-22 4:17 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 19-Dec-22 | Payment of Exercise | 461 | $30.03 | $13,843.80 | (1%) 32.67K to 32.21K | |
| 02-Mar-22 6:09 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 28-Feb-22 | Grant | 8,000 | -- | -- | 32% 24.67K to 32.67K | |
| 04-Feb-22 4:58 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 02-Feb-22 | Payment of Exercise | 805 | $45.03 | $36,249.10 | (3%) 25.47K to 24.67K | |
| 01-Feb-22 6:45 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 31-Jan-22 | Payment of Exercise | 626 | $45.94 | $28,758.40 | (2%) 26.1K to 25.47K | (14%) |
| 11-Jan-22 4:40 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 07-Jan-22 | Payment of Exercise | 263 | $50.63 | $13,315.70 | (< 1%) 26.36K to 26.1K | (4%) |
| 07-Jan-22 4:37 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 05-Jan-22 | Payment of Exercise | 738 | $50.69 | $37,409.20 | (3%) 27.1K to 26.36K | (1%) |
| 21-Dec-21 7:10 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 20-Dec-21 | Payment of Exercise | 467 | $55.42 | $25,881.10 | (2%) 27.57K to 27.1K | 0% |
| 04-Feb-21 5:09 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 02-Feb-21 | Grant | 8,900 | -- | -- | 48% 18.67K to 27.57K | |
| 02-Feb-21 5:08 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 29-Jan-21 | Payment of Exercise | 637 | $46.67 | $29,728.80 | (3%) 19.3K to 18.67K | (4%) |
| 11-Jan-21 8:06 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 07-Jan-21 | Payment of Exercise | 237 | $50.97 | $12,079.90 | (2%) 14.54K to 14.3K | 3% |
| 07-Jan-21 4:29 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 05-Jan-21 | Payment of Exercise | 746 | $50.02 | $37,314.90 | (5%) 15.29K to 14.54K | 0% |
| 22-Jan-21 5:21 PM View: | Eagle Pharmaceuticals, Inc. (EGRX) | 18-Dec-20 | Grant | 5,000 | -- | -- | 35% 14.3K to 19.3K |